The risk of having a baby with Down syndrome increases with maternal age. As women get older, their chances of giving birth to a child with this condition also increase. To assess this risk, healthcare providers often recommend undergoing a screening test during the second trimester of pregnancy.
During the second trimester, typically between weeks 15 and 20, a blood test called the quad screen is performed. This test measures specific substances in the mother's blood to evaluate the likelihood of chromosomal abnormalities, including Down syndrome.
The quad screen measures four markers: alpha-fetoprotein (AFP), human chorionic gonadotropin (hCG), unconjugated estriol (uE3), and inhibin A. Based on these measurements, an estimated risk for Down syndrome can be calculated.
It's important to note that this screening test does not provide a definitive diagnosis but rather an estimate of the risk. If the results indicate an increased risk, further diagnostic tests such as amniocentesis or chorionic villus sampling may be recommended to confirm or rule out Down syndrome.
It is crucial for expectant mothers to discuss their options and concerns with their healthcare provider regarding prenatal testing and potential risks associated with advanced maternal age.